|
|
chromatin modification
|
GO:0016568 |
187 |
0.210
|
|
|
|
regulation of cell cycle
|
GO:0051726 |
281 |
0.120
|
|
|
|
single organismal cell cell adhesion
|
GO:0016337 |
131 |
0.119
|
|
|
|
lymphocyte differentiation
|
GO:0030098 |
242 |
0.102
|
Mouse |
|
|
chromatin organization
|
GO:0006325 |
206 |
0.102
|
|
|
|
male gamete generation
|
GO:0048232 |
285 |
0.099
|
Mouse |
|
|
macromolecule catabolic process
|
GO:0009057 |
281 |
0.097
|
|
|
|
small gtpase mediated signal transduction
|
GO:0007264 |
97 |
0.094
|
|
|
|
mitotic cell cycle
|
GO:0000278 |
195 |
0.091
|
|
|
|
negative regulation of cellular protein metabolic process
|
GO:0032269 |
247 |
0.088
|
|
|
|
translation
|
GO:0006412 |
93 |
0.083
|
|
|
|
proteasomal protein catabolic process
|
GO:0010498 |
98 |
0.082
|
|
|
|
regulation of nucleotide metabolic process
|
GO:0006140 |
169 |
0.081
|
|
|
|
gtp catabolic process
|
GO:0006184 |
143 |
0.078
|
|
|
|
regulation of mitotic cell cycle
|
GO:0007346 |
126 |
0.076
|
|
|
|
compound eye development
|
GO:0048749 |
1 |
0.074
|
|
|
|
heterocycle catabolic process
|
GO:0046700 |
280 |
0.070
|
|
|
|
stem cell maintenance
|
GO:0019827 |
130 |
0.069
|
|
|
|
t cell differentiation
|
GO:0030217 |
174 |
0.068
|
Mouse |
|
|
response to oxidative stress
|
GO:0006979 |
123 |
0.068
|
|
|
|
neuroblast differentiation
|
GO:0014016 |
2 |
0.067
|
|
|
|
regionalization
|
GO:0003002 |
337 |
0.066
|
|
|
|
cellular response to insulin stimulus
|
GO:0032869 |
78 |
0.066
|
|
|
|
t cell activation
|
GO:0042110 |
289 |
0.065
|
Mouse |
|
|
microtubule based process
|
GO:0007017 |
236 |
0.063
|
|
|
|
dorsal ventral axon guidance
|
GO:0033563 |
3 |
0.063
|
|
|
|
guanosine containing compound metabolic process
|
GO:1901068 |
144 |
0.062
|
|
|
|
regulation of cell cycle process
|
GO:0010564 |
160 |
0.061
|
|
|
|
rho protein signal transduction
|
GO:0007266 |
32 |
0.061
|
|
|
|
notch signaling pathway
|
GO:0007219 |
71 |
0.061
|
|
|
|
protein catabolic process
|
GO:0030163 |
221 |
0.058
|
|
|
|
mitotic cell cycle process
|
GO:1903047 |
159 |
0.056
|
|
|
|
regulation of mitotic cell cycle phase transition
|
GO:1901990 |
73 |
0.054
|
|
|
|
regulation of cellular amino acid metabolic process
|
GO:0006521 |
5 |
0.054
|
|
|
|
macromolecule methylation
|
GO:0043414 |
120 |
0.051
|
|
|
|
g1 s transition of mitotic cell cycle
|
GO:0000082 |
57 |
0.051
|
|
|
|
ribonucleotide catabolic process
|
GO:0009261 |
208 |
0.050
|
|
|
|
cell fate commitment
|
GO:0045165 |
210 |
0.049
|
|
|
|
carbohydrate metabolic process
|
GO:0005975 |
230 |
0.049
|
|
|
|
sequestering of metal ion
|
GO:0051238 |
19 |
0.048
|
|
|
|
negative regulation of protein metabolic process
|
GO:0051248 |
282 |
0.048
|
|
|
|
modification dependent protein catabolic process
|
GO:0019941 |
133 |
0.048
|
|
|
|
rhythmic process
|
GO:0048511 |
174 |
0.047
|
|
|
|
stem cell differentiation
|
GO:0048863 |
268 |
0.047
|
|
|
|
regulation of cellular ketone metabolic process
|
GO:0010565 |
66 |
0.047
|
|
|
|
amide transport
|
GO:0042886 |
138 |
0.047
|
|
|
|
regulation of intracellular transport
|
GO:0032386 |
159 |
0.047
|
|
|
|
leukocyte differentiation
|
GO:0002521 |
342 |
0.046
|
Mouse |
|
|
stem cell development
|
GO:0048864 |
219 |
0.046
|
|
|
|
purine ribonucleoside catabolic process
|
GO:0046130 |
205 |
0.046
|
|
|
|
neuron projection guidance
|
GO:0097485 |
141 |
0.045
|
|
|
|
cellular response to organonitrogen compound
|
GO:0071417 |
145 |
0.042
|
|
|
|
regulation of nucleotide catabolic process
|
GO:0030811 |
122 |
0.042
|
|
|
|
peptidyl amino acid modification
|
GO:0018193 |
336 |
0.042
|
|
|
|
microtubule cytoskeleton organization
|
GO:0000226 |
157 |
0.042
|
|
|
|
methylation
|
GO:0032259 |
134 |
0.041
|
|
|
|
purine ribonucleoside triphosphate metabolic process
|
GO:0009205 |
220 |
0.041
|
|
|
|
cellular macromolecule catabolic process
|
GO:0044265 |
206 |
0.041
|
|
|
|
spermatogenesis
|
GO:0007283 |
284 |
0.041
|
Mouse |
|
|
cilium morphogenesis
|
GO:0060271 |
102 |
0.041
|
|
|
|
positive regulation of cell development
|
GO:0010720 |
237 |
0.041
|
|
|
|
negative regulation of cell development
|
GO:0010721 |
169 |
0.041
|
|
|
|
cellular homeostasis
|
GO:0019725 |
240 |
0.040
|
|
|
|
nucleoside metabolic process
|
GO:0009116 |
246 |
0.040
|
|
|
|
nucleoside triphosphate catabolic process
|
GO:0009143 |
205 |
0.039
|
|
|
|
mammary gland epithelium development
|
GO:0061180 |
65 |
0.038
|
|
|
|
positive regulation of cell cycle
|
GO:0045787 |
92 |
0.038
|
|
|
|
cellular chemical homeostasis
|
GO:0055082 |
215 |
0.038
|
|
|
|
muscle cell differentiation
|
GO:0042692 |
261 |
0.038
|
|
|
|
hexose metabolic process
|
GO:0019318 |
98 |
0.038
|
|
|
|
purine nucleoside catabolic process
|
GO:0006152 |
205 |
0.038
|
|
|
|
nucleoside triphosphate metabolic process
|
GO:0009141 |
230 |
0.037
|
|
|
|
camera type eye development
|
GO:0043010 |
266 |
0.037
|
|
|
|
appendage morphogenesis
|
GO:0035107 |
149 |
0.037
|
|
|
|
positive regulation of fibroblast proliferation
|
GO:0048146 |
20 |
0.036
|
|
|
|
purine ribonucleotide catabolic process
|
GO:0009154 |
208 |
0.036
|
|
|
|
regulation of protein kinase activity
|
GO:0045859 |
232 |
0.035
|
|
|
|
ras protein signal transduction
|
GO:0007265 |
77 |
0.035
|
|
|
|
regulation of translation
|
GO:0006417 |
71 |
0.035
|
|
|
|
maintenance of location
|
GO:0051235 |
89 |
0.035
|
|
|
|
negative regulation of nervous system development
|
GO:0051961 |
156 |
0.035
|
|
|
|
neural precursor cell proliferation
|
GO:0061351 |
121 |
0.034
|
|
|
|
positive regulation of cellular amino acid metabolic process
|
GO:0045764 |
3 |
0.034
|
|
|
|
muscle tissue development
|
GO:0060537 |
308 |
0.034
|
|
|
|
posttranscriptional regulation of gene expression
|
GO:0010608 |
155 |
0.034
|
|
|
|
ribonucleoside catabolic process
|
GO:0042454 |
206 |
0.034
|
|
|
|
cellular ketone metabolic process
|
GO:0042180 |
84 |
0.034
|
|
|
|
cellular amino acid metabolic process
|
GO:0006520 |
103 |
0.033
|
|
|
|
nuclear import
|
GO:0051170 |
95 |
0.033
|
|
|
|
ovulation cycle
|
GO:0042698 |
59 |
0.033
|
|
|
|
gene silencing
|
GO:0016458 |
38 |
0.033
|
|
|
|
purine nucleoside triphosphate catabolic process
|
GO:0009146 |
203 |
0.032
|
|
|
|
transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0007178 |
194 |
0.032
|
|
|
|
regulation of cell cycle phase transition
|
GO:1901987 |
77 |
0.032
|
|
|
|
purine nucleoside metabolic process
|
GO:0042278 |
241 |
0.032
|
|
|
|
regulation of secretion
|
GO:0051046 |
274 |
0.032
|
|
|
|
development of primary sexual characteristics
|
GO:0045137 |
143 |
0.032
|
Mouse |
|
|
histone modification
|
GO:0016570 |
159 |
0.032
|
|
|
|
gland development
|
GO:0048732 |
330 |
0.031
|
|
|
|
regulation of ras gtpase activity
|
GO:0032318 |
88 |
0.031
|
|
|
|
skeletal muscle organ development
|
GO:0060538 |
163 |
0.031
|
|
|
|
somitogenesis
|
GO:0001756 |
69 |
0.031
|
|
|
|
positive regulation of nucleotide catabolic process
|
GO:0030813 |
88 |
0.031
|
|
|
|
cation homeostasis
|
GO:0055080 |
212 |
0.031
|
|
|
|
cellular protein catabolic process
|
GO:0044257 |
155 |
0.031
|
|
|
|
positive regulation of mapk cascade
|
GO:0043410 |
170 |
0.031
|
|
|
|
nitrogen compound transport
|
GO:0071705 |
271 |
0.030
|
|
|
|
protein import
|
GO:0017038 |
101 |
0.030
|
|
|
|
purine ribonucleotide metabolic process
|
GO:0009150 |
290 |
0.030
|
|
|
|
positive regulation of protein phosphorylation
|
GO:0001934 |
242 |
0.030
|
|
|
|
regulation of secretion by cell
|
GO:1903530 |
249 |
0.030
|
|
|
|
fucose metabolic process
|
GO:0006004 |
1 |
0.030
|
|
|
|
positive regulation of gtp catabolic process
|
GO:0033126 |
85 |
0.030
|
|
|
|
nucleoside phosphate catabolic process
|
GO:1901292 |
222 |
0.030
|
|
|
|
glial cell differentiation
|
GO:0010001 |
131 |
0.030
|
|
|
|
sequestering of calcium ion
|
GO:0051208 |
18 |
0.029
|
|
|
|
cation transport
|
GO:0006812 |
399 |
0.029
|
|
|
|
organophosphate catabolic process
|
GO:0046434 |
232 |
0.029
|
|
|
|
monosaccharide metabolic process
|
GO:0005996 |
106 |
0.029
|
|
|
|
ovarian follicle development
|
GO:0001541 |
40 |
0.029
|
|
|
|
regulation of neuron differentiation
|
GO:0045664 |
281 |
0.029
|
|
|
|
striated muscle tissue development
|
GO:0014706 |
293 |
0.029
|
|
|
|
regulation of chromosome organization
|
GO:0033044 |
83 |
0.029
|
|
|
|
regulation of sequence specific dna binding transcription factor activity
|
GO:0051090 |
106 |
0.029
|
|
|
|
regulation of purine nucleotide metabolic process
|
GO:1900542 |
169 |
0.028
|
|
|
|
negative regulation of sequence specific dna binding transcription factor activity
|
GO:0043433 |
40 |
0.028
|
|
|
|
cellular response to peptide hormone stimulus
|
GO:0071375 |
92 |
0.028
|
|
|
|
nucleobase containing small molecule metabolic process
|
GO:0055086 |
352 |
0.028
|
|
|
|
cellular nitrogen compound catabolic process
|
GO:0044270 |
280 |
0.028
|
|
|
|
protein localization to nucleus
|
GO:0034504 |
121 |
0.028
|
|
|
|
cartilage development
|
GO:0051216 |
140 |
0.028
|
|
|
|
actin cytoskeleton organization
|
GO:0030036 |
220 |
0.028
|
|
|
|
negative regulation of cell proliferation
|
GO:0008285 |
296 |
0.027
|
|
|
|
ribose phosphate metabolic process
|
GO:0019693 |
291 |
0.027
|
|
|
|
cellular amine metabolic process
|
GO:0044106 |
44 |
0.027
|
|
|
|
cellular response to peptide
|
GO:1901653 |
92 |
0.027
|
|
|
|
regulation of protein stability
|
GO:0031647 |
52 |
0.027
|
|
|
|
positive regulation of organelle organization
|
GO:0010638 |
128 |
0.027
|
|
|
|
mrna transcription from rna polymerase ii promoter
|
GO:0042789 |
4 |
0.026
|
|
|
|
negative regulation of translational initiation
|
GO:0045947 |
4 |
0.026
|
|
|
|
regulation of peptidase activity
|
GO:0052547 |
96 |
0.026
|
|
|
|
negative regulation of molecular function
|
GO:0044092 |
258 |
0.026
|
|
|
|
blastocyst development
|
GO:0001824 |
80 |
0.026
|
|
|
|
regulation of rho gtpase activity
|
GO:0032319 |
58 |
0.026
|
|
|
|
negative regulation of intracellular protein transport
|
GO:0090317 |
27 |
0.026
|
|
|
|
chemotaxis
|
GO:0006935 |
247 |
0.026
|
|
|
|
rna interference
|
GO:0016246 |
2 |
0.026
|
|
|
|
nucleotide metabolic process
|
GO:0009117 |
332 |
0.025
|
|
|
|
placenta development
|
GO:0001890 |
140 |
0.025
|
|
|
|
neuroblast fate determination
|
GO:0007400 |
1 |
0.025
|
|
|
|
protein import into nucleus
|
GO:0006606 |
95 |
0.025
|
|
|
|
nucleoside catabolic process
|
GO:0009164 |
206 |
0.025
|
|
|
|
cerebellar granule cell precursor tangential migration
|
GO:0021935 |
1 |
0.025
|
|
|
|
nuclear transport
|
GO:0051169 |
139 |
0.025
|
|
|
|
regulation of organelle organization
|
GO:0033043 |
289 |
0.025
|
|
|
|
lipid homeostasis
|
GO:0055088 |
63 |
0.025
|
|
|
|
purine nucleotide catabolic process
|
GO:0006195 |
211 |
0.025
|
|
|
|
regulation of apoptotic signaling pathway
|
GO:2001233 |
197 |
0.025
|
|
|
|
purine ribonucleoside triphosphate catabolic process
|
GO:0009207 |
199 |
0.025
|
|
|
|
negative regulation of neuron differentiation
|
GO:0045665 |
101 |
0.025
|
|
|
|
positive regulation of purine nucleotide catabolic process
|
GO:0033123 |
88 |
0.025
|
|
|
|
neuroblast fate commitment
|
GO:0014017 |
1 |
0.025
|
|
|
|
leukocyte proliferation
|
GO:0070661 |
172 |
0.024
|
|
|
|
hematopoietic progenitor cell differentiation
|
GO:0002244 |
143 |
0.024
|
|
|
|
regulation of nucleoside metabolic process
|
GO:0009118 |
130 |
0.024
|
|
|
|
proteolysis involved in cellular protein catabolic process
|
GO:0051603 |
147 |
0.024
|
|
|
|
protein maturation
|
GO:0051604 |
176 |
0.024
|
|
|
|
response to insulin
|
GO:0032868 |
100 |
0.023
|
|
|
|
carbohydrate derivative catabolic process
|
GO:1901136 |
231 |
0.023
|
|
|
|
response to peptide
|
GO:1901652 |
136 |
0.023
|
|
|
|
aromatic compound catabolic process
|
GO:0019439 |
286 |
0.023
|
|
|
|
homeostasis of number of cells
|
GO:0048872 |
210 |
0.023
|
|
|
|
regulation of gtp catabolic process
|
GO:0033124 |
113 |
0.023
|
|
|
|
lens development in camera type eye
|
GO:0002088 |
62 |
0.023
|
|
|
|
positive regulation of protein modification process
|
GO:0031401 |
299 |
0.023
|
|
|
|
photoreceptor cell morphogenesis
|
GO:0008594 |
3 |
0.023
|
|
|
|
single organism nuclear import
|
GO:1902593 |
95 |
0.023
|
|
|
|
cellular calcium ion homeostasis
|
GO:0006874 |
119 |
0.022
|
|
|
|
female sex differentiation
|
GO:0046660 |
84 |
0.022
|
|
|
|
neural tube development
|
GO:0021915 |
160 |
0.022
|
|
|
|
transdifferentiation
|
GO:0060290 |
1 |
0.022
|
|
|
|
positive regulation of cell cycle process
|
GO:0090068 |
61 |
0.022
|
|
|
|
negative regulation of apoptotic signaling pathway
|
GO:2001234 |
104 |
0.022
|
|
|
|
epithelial tube morphogenesis
|
GO:0060562 |
303 |
0.022
|
|
|
|
ectodermal cell differentiation
|
GO:0010668 |
3 |
0.022
|
|
|
|
dna metabolic process
|
GO:0006259 |
303 |
0.022
|
|
|
|
cellular response to hormone stimulus
|
GO:0032870 |
150 |
0.021
|
|
|
|
neural tube closure
|
GO:0001843 |
90 |
0.021
|
|
|
|
organic cyclic compound catabolic process
|
GO:1901361 |
295 |
0.021
|
|
|
|
single organism cell adhesion
|
GO:0098602 |
156 |
0.021
|
|
|
|
apoptotic signaling pathway
|
GO:0097190 |
306 |
0.021
|
|
|
|
nucleocytoplasmic transport
|
GO:0006913 |
139 |
0.021
|
|
|
|
negative regulation of protein modification process
|
GO:0031400 |
163 |
0.021
|
|
|
|
regulation of hydrolase activity
|
GO:0051336 |
246 |
0.021
|
|
|
|
regulation of leukocyte differentiation
|
GO:1902105 |
159 |
0.021
|
|
|
|
amine metabolic process
|
GO:0009308 |
45 |
0.021
|
|
|
|
digestive tract development
|
GO:0048565 |
190 |
0.021
|
|
|
|
inflammatory response
|
GO:0006954 |
244 |
0.021
|
|
|
|
germ cell development
|
GO:0007281 |
185 |
0.021
|
|
|
|
b cell activation
|
GO:0042113 |
161 |
0.021
|
|
|
|
ribonucleoside triphosphate catabolic process
|
GO:0009203 |
199 |
0.021
|
|
|
|
axonogenesis
|
GO:0007409 |
274 |
0.020
|
|
|
|
cell adhesion
|
GO:0007155 |
329 |
0.020
|
|
|
|
purine nucleoside triphosphate metabolic process
|
GO:0009144 |
226 |
0.020
|
|
|
|
forebrain development
|
GO:0030900 |
302 |
0.020
|
|
|
|
regulation of establishment of protein localization
|
GO:0070201 |
181 |
0.020
|
|
|
|
response to inorganic substance
|
GO:0010035 |
96 |
0.020
|
|
|
|
negative regulation of cell activation
|
GO:0050866 |
111 |
0.020
|
|
|
|
positive regulation of transferase activity
|
GO:0051347 |
167 |
0.020
|
|
|
|
regulation of chromatin modification
|
GO:1903308 |
57 |
0.020
|
|
|
|
gonad development
|
GO:0008406 |
141 |
0.020
|
Mouse |
|
|
establishment or maintenance of microtubule cytoskeleton polarity
|
GO:0030951 |
1 |
0.020
|
|
|
|
antimicrobial peptide biosynthetic process
|
GO:0002777 |
2 |
0.020
|
|
|
|
positive regulation of mitotic cell cycle
|
GO:0045931 |
41 |
0.020
|
|
|
|
peptide transport
|
GO:0015833 |
133 |
0.019
|
|
|
|
protein modification by small protein conjugation or removal
|
GO:0070647 |
207 |
0.019
|
|
|
|
regulation of peptide hormone secretion
|
GO:0090276 |
75 |
0.019
|
|
|
|
telencephalon development
|
GO:0021537 |
186 |
0.019
|
|
|
|
skeletal system development
|
GO:0001501 |
356 |
0.019
|
|
|
|
positive regulation of nucleoside metabolic process
|
GO:0045979 |
91 |
0.019
|
|
|
|
ribonucleoside metabolic process
|
GO:0009119 |
245 |
0.019
|
|
|
|
gtp metabolic process
|
GO:0046039 |
144 |
0.019
|
|
|
|
immune effector process
|
GO:0002252 |
321 |
0.019
|
|
|
|
positive regulation of nervous system development
|
GO:0051962 |
221 |
0.019
|
|
|
|
negative regulation of phosphorylation
|
GO:0042326 |
166 |
0.019
|
|
|
|
fatty acid metabolic process
|
GO:0006631 |
121 |
0.019
|
|
|
|
trophectodermal cell differentiation
|
GO:0001829 |
21 |
0.019
|
|
|
|
myotube differentiation
|
GO:0014902 |
105 |
0.019
|
|
|
|
regulation of cellular catabolic process
|
GO:0031329 |
242 |
0.019
|
|
|
|
purine nucleotide metabolic process
|
GO:0006163 |
302 |
0.018
|
|
|
|
nucleotide catabolic process
|
GO:0009166 |
217 |
0.018
|
|
|
|
regulation of fibroblast proliferation
|
GO:0048145 |
34 |
0.018
|
|
|
|
ribonucleoside triphosphate metabolic process
|
GO:0009199 |
220 |
0.018
|
|
|
|
organ regeneration
|
GO:0031100 |
2 |
0.018
|
|
|
|
regulation of proteolysis
|
GO:0030162 |
164 |
0.018
|
|
|
|
antimicrobial peptide production
|
GO:0002775 |
2 |
0.018
|
|
|
|
compartment pattern specification
|
GO:0007386 |
4 |
0.018
|
|
|
|
negative regulation of cell cycle phase transition
|
GO:1901988 |
48 |
0.018
|
|
|
|
regulation of notch signaling pathway
|
GO:0008593 |
35 |
0.018
|
|
|
|
purine containing compound catabolic process
|
GO:0072523 |
213 |
0.018
|
|
|
|
regulation of stem cell differentiation
|
GO:2000736 |
50 |
0.018
|
|
|
|
chromatin remodeling
|
GO:0006338 |
32 |
0.018
|
|
|
|
cell type specific apoptotic process
|
GO:0097285 |
268 |
0.018
|
|
|
|
regulation of homeostatic process
|
GO:0032844 |
182 |
0.018
|
|
|
|
positive regulation of cytoskeleton organization
|
GO:0051495 |
49 |
0.018
|
|
|
|
protein alkylation
|
GO:0008213 |
81 |
0.018
|
|
|
|
skeletal system morphogenesis
|
GO:0048705 |
203 |
0.018
|
|
|
|
regulation of t cell differentiation
|
GO:0045580 |
83 |
0.018
|
|
|
|
regulation of binding
|
GO:0051098 |
111 |
0.018
|
|
|
|
spleen development
|
GO:0048536 |
39 |
0.018
|
|
|
|
nucleoside phosphate metabolic process
|
GO:0006753 |
338 |
0.018
|
|
|
|
regulation of mrna metabolic process
|
GO:1903311 |
43 |
0.018
|
|
|
|
primary neural tube formation
|
GO:0014020 |
95 |
0.018
|
|
|
|
regulation of stem cell maintenance
|
GO:2000036 |
17 |
0.018
|
|
|
|
multi multicellular organism process
|
GO:0044706 |
109 |
0.018
|
|
|
|
protein o linked glycosylation
|
GO:0006493 |
16 |
0.018
|
|
|
|
protein methylation
|
GO:0006479 |
81 |
0.017
|
|
|
|
mrna processing
|
GO:0006397 |
63 |
0.017
|
|
|
|
macromolecule glycosylation
|
GO:0043413 |
55 |
0.017
|
|
|
|
protein processing
|
GO:0016485 |
163 |
0.017
|
|
|
|
positive regulation of cellular amine metabolic process
|
GO:0033240 |
5 |
0.017
|
|
|
|
positive regulation of hydrolase activity
|
GO:0051345 |
148 |
0.017
|
|
|
|
habituation
|
GO:0046959 |
3 |
0.017
|
|
|
|
negative regulation of phosphorus metabolic process
|
GO:0010563 |
184 |
0.017
|
|
|
|
positive regulation of cytosolic calcium ion concentration
|
GO:0007204 |
65 |
0.017
|
|
|
|
regulation of asymmetric cell division
|
GO:0009786 |
4 |
0.017
|
|
|
|
regulation of lymphocyte differentiation
|
GO:0045619 |
107 |
0.017
|
|
|
|
regulation of cytoplasmic transport
|
GO:1903649 |
112 |
0.017
|
|
|
|
regulation of antimicrobial humoral response
|
GO:0002759 |
3 |
0.017
|
|
|
|
response to organonitrogen compound
|
GO:0010243 |
246 |
0.017
|
|
|
|
cellular lipid metabolic process
|
GO:0044255 |
323 |
0.017
|
|
|
|
peptide secretion
|
GO:0002790 |
114 |
0.017
|
|
|
|
triglyceride biosynthetic process
|
GO:0019432 |
17 |
0.017
|
|
|
|
negative regulation of cellular amine metabolic process
|
GO:0033239 |
1 |
0.017
|
|
|
|
male sex differentiation
|
GO:0046661 |
109 |
0.017
|
Mouse |
|
|
carbohydrate homeostasis
|
GO:0033500 |
128 |
0.017
|
|
|
|
metal ion homeostasis
|
GO:0055065 |
189 |
0.016
|
|
|
|
response to osmotic stress
|
GO:0006970 |
21 |
0.016
|
|
|
|
developmental maturation
|
GO:0021700 |
193 |
0.016
|
|
|
|
regulation of neuron apoptotic process
|
GO:0043523 |
122 |
0.016
|
|
|
|
positive regulation of gtpase activity
|
GO:0043547 |
85 |
0.016
|
|
|
|
regulation of intrinsic apoptotic signaling pathway
|
GO:2001242 |
61 |
0.016
|
|
|
|
response to peptide hormone
|
GO:0043434 |
127 |
0.016
|
|
|
|
fibroblast proliferation
|
GO:0048144 |
35 |
0.016
|
|
|
|
limb morphogenesis
|
GO:0035108 |
149 |
0.016
|
|
|
|
regulation of protein localization
|
GO:0032880 |
231 |
0.016
|
|
|
|
wnt signaling pathway
|
GO:0016055 |
188 |
0.016
|
|
|
|
locomotory behavior
|
GO:0007626 |
195 |
0.016
|
|
|
|
regulation of purine nucleotide catabolic process
|
GO:0033121 |
122 |
0.016
|
|
|
|
blood vessel morphogenesis
|
GO:0048514 |
285 |
0.016
|
|
|
|
intracellular mrna localization
|
GO:0008298 |
4 |
0.016
|
|
|
|
cytoplasmic transport
|
GO:0016482 |
234 |
0.016
|
|
|
|
ribonucleotide metabolic process
|
GO:0009259 |
291 |
0.016
|
|
|
|
cellular divalent inorganic cation homeostasis
|
GO:0072503 |
127 |
0.016
|
|
|
|
negative regulation of protein phosphorylation
|
GO:0001933 |
126 |
0.016
|
|
|
|
cell cycle g1 s phase transition
|
GO:0044843 |
57 |
0.016
|
|
|
|
signal transduction by p53 class mediator
|
GO:0072331 |
51 |
0.016
|
|
|
|
adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains
|
GO:0002460 |
145 |
0.016
|
|
|
|
stem cell proliferation
|
GO:0072089 |
117 |
0.016
|
|
|
|
regulation of cell activation
|
GO:0050865 |
289 |
0.016
|
|
|
|
myeloid cell differentiation
|
GO:0030099 |
233 |
0.016
|
|
|
|
metanephric loop of henle development
|
GO:0072236 |
4 |
0.015
|
|
|
|
positive regulation of nucleotide metabolic process
|
GO:0045981 |
114 |
0.015
|
|
|
|
guanosine containing compound catabolic process
|
GO:1901069 |
144 |
0.015
|
|
|
|
regulation of cytokine production
|
GO:0001817 |
266 |
0.015
|
|
|
|
lymphocyte proliferation
|
GO:0046651 |
164 |
0.015
|
|
|
|
cellularization
|
GO:0007349 |
1 |
0.015
|
|
|
|
regulation of cysteine type endopeptidase activity
|
GO:2000116 |
65 |
0.015
|
|
|
|
response to acid chemical
|
GO:0001101 |
111 |
0.015
|
|
|
|
protein modification by small protein conjugation
|
GO:0032446 |
187 |
0.015
|
|
|
|
female gonad development
|
GO:0008585 |
71 |
0.015
|
|
|
|
regulation of mammary gland epithelial cell proliferation
|
GO:0033599 |
12 |
0.015
|
|
|
|
positive regulation of epithelial cell proliferation
|
GO:0050679 |
68 |
0.015
|
|
|
|
sensory organ morphogenesis
|
GO:0090596 |
242 |
0.015
|
|
|
|
glycosyl compound metabolic process
|
GO:1901657 |
246 |
0.015
|
|
|
|
regulation of neuron death
|
GO:1901214 |
134 |
0.015
|
|
|
|
branching morphogenesis of an epithelial tube
|
GO:0048754 |
159 |
0.015
|
|
|
|
mitral valve development
|
GO:0003174 |
4 |
0.015
|
|
|
|
digestive system development
|
GO:0055123 |
200 |
0.015
|
|
|
|
positive regulation of cellular catabolic process
|
GO:0031331 |
148 |
0.015
|
|
|
|
regulation of cell migration
|
GO:0030334 |
219 |
0.014
|
|
|
|
t cell proliferation
|
GO:0042098 |
120 |
0.014
|
|
|
|
negative regulation of homeostatic process
|
GO:0032845 |
71 |
0.014
|
|
|
|
regulation of kinase activity
|
GO:0043549 |
249 |
0.014
|
|
|
|
carbohydrate derivative biosynthetic process
|
GO:1901137 |
183 |
0.014
|
|
|
|
establishment of protein localization to organelle
|
GO:0072594 |
118 |
0.014
|
|
|
|
oogenesis
|
GO:0048477 |
56 |
0.014
|
|
|
|
protein ubiquitination
|
GO:0016567 |
171 |
0.014
|
|
|
|
epithelial cell proliferation
|
GO:0050673 |
174 |
0.014
|
|
|
|
endomembrane system organization
|
GO:0010256 |
147 |
0.014
|
|
|
|
regulation of ossification
|
GO:0030278 |
112 |
0.014
|
|
|
|
mrna metabolic process
|
GO:0016071 |
84 |
0.014
|
|
|
|
dendrite development
|
GO:0016358 |
115 |
0.014
|
|
|
|
asymmetric neuroblast division
|
GO:0055059 |
1 |
0.014
|
|
|
|
regulation of protein binding
|
GO:0043393 |
60 |
0.014
|
|
|
|
negative regulation of immune system process
|
GO:0002683 |
209 |
0.014
|
|
|
|
regulation of t cell activation
|
GO:0050863 |
170 |
0.014
|
|
|
|
regulation of embryonic development
|
GO:0045995 |
71 |
0.014
|
|
|
|
regulation of lymphocyte anergy
|
GO:0002911 |
4 |
0.014
|
|
|
|
limb development
|
GO:0060173 |
166 |
0.014
|
|
|
|
protein heterotrimerization
|
GO:0070208 |
8 |
0.014
|
|
|
|
negative regulation of mitotic cell cycle
|
GO:0045930 |
58 |
0.014
|
|
|
|
cell maturation
|
GO:0048469 |
127 |
0.014
|
|
|
|
transmembrane transport
|
GO:0055085 |
412 |
0.014
|
|
|
|
regulation of cell adhesion
|
GO:0030155 |
154 |
0.014
|
|
|
|
divalent inorganic cation homeostasis
|
GO:0072507 |
138 |
0.014
|
|
|
|
regulation of protein serine threonine kinase activity
|
GO:0071900 |
157 |
0.014
|
|
|
|
regulation of actin polymerization or depolymerization
|
GO:0008064 |
45 |
0.013
|
|
|
|
development of primary female sexual characteristics
|
GO:0046545 |
73 |
0.013
|
|
|
|
mesonephros development
|
GO:0001823 |
97 |
0.013
|
|
|
|
asymmetric stem cell division
|
GO:0098722 |
3 |
0.013
|
|
|
|
cytokine production
|
GO:0001816 |
319 |
0.013
|
|
|
|
anion transmembrane transport
|
GO:0098656 |
71 |
0.013
|
|
|
|
adult behavior
|
GO:0030534 |
135 |
0.013
|
|
|
|
calcium ion homeostasis
|
GO:0055074 |
127 |
0.013
|
|
|
|
divalent inorganic cation transport
|
GO:0072511 |
178 |
0.013
|
|
|
|
male gonad development
|
GO:0008584 |
88 |
0.013
|
Mouse |
|
|
nuclear division
|
GO:0000280 |
158 |
0.013
|
|
|
|
dephosphorylation
|
GO:0016311 |
129 |
0.013
|
|
|
|
regulation of transferase activity
|
GO:0051338 |
263 |
0.013
|
|
|
|
regulation of neuron projection development
|
GO:0010975 |
169 |
0.013
|
|
|
|
regulation of cell cycle g2 m phase transition
|
GO:1902749 |
10 |
0.013
|
|
|
|
defecation
|
GO:0030421 |
1 |
0.013
|
|
|
|
second messenger mediated signaling
|
GO:0019932 |
73 |
0.013
|
|
|
|
regulation of cell projection organization
|
GO:0031344 |
206 |
0.013
|
|
|
|
regulation of lymphocyte activation
|
GO:0051249 |
240 |
0.013
|
|
|
|
dna methylation
|
GO:0006306 |
43 |
0.013
|
|
|
|
glutamine family amino acid biosynthetic process
|
GO:0009084 |
2 |
0.013
|
|
|
|
t cell differentiation in thymus
|
GO:0033077 |
77 |
0.013
|
|
|
|
positive regulation of fat cell differentiation
|
GO:0045600 |
32 |
0.013
|
|
|
|
angiogenesis
|
GO:0001525 |
201 |
0.013
|
|
|
|
neuroblast proliferation
|
GO:0007405 |
49 |
0.013
|
|
|
|
organelle fission
|
GO:0048285 |
170 |
0.013
|
|
|
|
vesicle organization
|
GO:0016050 |
60 |
0.013
|
|
|
|
adaptive immune response
|
GO:0002250 |
155 |
0.013
|
|
|
|
cytokine biosynthetic process
|
GO:0042089 |
68 |
0.013
|
|
|
|
regulation of mast cell differentiation
|
GO:0060375 |
3 |
0.013
|
|
|
|
fat cell differentiation
|
GO:0045444 |
160 |
0.012
|
|
|
|
purine containing compound metabolic process
|
GO:0072521 |
311 |
0.012
|
|
|
|
peptidyl lysine modification
|
GO:0018205 |
77 |
0.012
|
|
|
|
negative regulation of cell cycle process
|
GO:0010948 |
69 |
0.012
|
|
|
|
rna processing
|
GO:0006396 |
105 |
0.012
|
|
|
|
negative regulation of synapse assembly
|
GO:0051964 |
3 |
0.012
|
|
|
|
transmission of nerve impulse
|
GO:0019226 |
76 |
0.012
|
|
|
|
oocyte axis specification
|
GO:0007309 |
2 |
0.012
|
|
|
|
learning or memory
|
GO:0007611 |
148 |
0.012
|
|
|
|
proteasome mediated ubiquitin dependent protein catabolic process
|
GO:0043161 |
88 |
0.012
|
|
|
|
regulation of cell division
|
GO:0051302 |
76 |
0.012
|
|
|
|
negative regulation of secretion by cell
|
GO:1903531 |
54 |
0.012
|
|
|
|
regulation of chromatin organization
|
GO:1902275 |
57 |
0.012
|
|
|
|
cellular protein complex assembly
|
GO:0043623 |
116 |
0.012
|
|
|
|
neuron apoptotic process
|
GO:0051402 |
142 |
0.012
|
|
|
|
thymus development
|
GO:0048538 |
41 |
0.012
|
|
|
|
defense response to other organism
|
GO:0098542 |
197 |
0.012
|
|
|
|
purine ribonucleoside metabolic process
|
GO:0046128 |
241 |
0.012
|
|
|
|
auditory receptor cell fate determination
|
GO:0042668 |
3 |
0.012
|
|
|
|
cell proliferation involved in outflow tract morphogenesis
|
GO:0061325 |
4 |
0.012
|
|
|
|
histone methylation
|
GO:0016571 |
71 |
0.012
|
|
|
|
intracellular receptor signaling pathway
|
GO:0030522 |
74 |
0.012
|
|
|
|
regulation of mrna splicing via spliceosome
|
GO:0048024 |
32 |
0.012
|
|
|
|
fatty acid transmembrane transport
|
GO:1902001 |
1 |
0.012
|
|
|
|
protein localization to cell junction
|
GO:1902414 |
3 |
0.012
|
|
|
|
muscle cell development
|
GO:0055001 |
133 |
0.012
|
|
|
|
establishment of endothelial blood brain barrier
|
GO:0014045 |
3 |
0.012
|
|
|
|
head morphogenesis
|
GO:0060323 |
34 |
0.012
|
|
|
|
positive regulation of programmed cell death
|
GO:0043068 |
218 |
0.012
|
|
|
|
positive regulation of cell activation
|
GO:0050867 |
158 |
0.012
|
|
|
|
establishment of planar polarity
|
GO:0001736 |
28 |
0.012
|
|
|
|
negative regulation of cell cycle
|
GO:0045786 |
123 |
0.012
|
|
|
|
kidney development
|
GO:0001822 |
213 |
0.012
|
|
|
|
negative regulation of cytokine production
|
GO:0001818 |
84 |
0.012
|
|
|
|
hormone secretion
|
GO:0046879 |
128 |
0.012
|
|
|
|
regulation of ion transport
|
GO:0043269 |
215 |
0.012
|
|
|
|
regulation of organ morphogenesis
|
GO:2000027 |
144 |
0.012
|
|
|
|
negative regulation of t cell activation
|
GO:0050868 |
65 |
0.012
|
|
|
|
covalent chromatin modification
|
GO:0016569 |
163 |
0.012
|
|
|
|
cilium assembly
|
GO:0042384 |
81 |
0.011
|
|
|
|
cell cycle g2 m phase transition
|
GO:0044839 |
20 |
0.011
|
|
|
|
protein oligomerization
|
GO:0051259 |
67 |
0.011
|
|
|
|
negative regulation of mitotic cell cycle phase transition
|
GO:1901991 |
45 |
0.011
|
|
|
|
regulation of cell motility
|
GO:2000145 |
236 |
0.011
|
|
|
|
negative regulation of cell size
|
GO:0045792 |
3 |
0.011
|
|
|
|
tissue migration
|
GO:0090130 |
68 |
0.011
|
|
|
|
positive regulation of purine nucleotide metabolic process
|
GO:1900544 |
114 |
0.011
|
|
|
|
positive regulation of mitotic cell cycle phase transition
|
GO:1901992 |
17 |
0.011
|
|
|
|
positive regulation of cell death
|
GO:0010942 |
224 |
0.011
|
|
|
|
positive regulation of secondary heart field cardioblast proliferation
|
GO:0072513 |
4 |
0.011
|
|
|
|
smoothened signaling pathway
|
GO:0007224 |
105 |
0.011
|
|
|
|
cell recognition
|
GO:0008037 |
83 |
0.011
|
|
|
|
regulation of system process
|
GO:0044057 |
200 |
0.011
|
|
|
|
positive regulation of mammary gland epithelial cell proliferation
|
GO:0033601 |
5 |
0.011
|
|
|
|
actin filament organization
|
GO:0007015 |
113 |
0.011
|
|
|
|
embryonic digestive tract development
|
GO:0048566 |
27 |
0.011
|
|
|
|
segmentation
|
GO:0035282 |
93 |
0.011
|
|
|
|
circulatory system process
|
GO:0003013 |
197 |
0.011
|
|
|
|
regulation of cysteine type endopeptidase activity involved in apoptotic signaling pathway
|
GO:2001267 |
4 |
0.011
|
|
|
|
regulation of peptide secretion
|
GO:0002791 |
77 |
0.011
|
|
|
|
regulation of cytoplasmic translation
|
GO:2000765 |
4 |
0.011
|
|
|
|
regulation of triglyceride biosynthetic process
|
GO:0010866 |
10 |
0.011
|
|
|
|
blastocyst formation
|
GO:0001825 |
33 |
0.011
|
|
|
|
somite development
|
GO:0061053 |
81 |
0.011
|
|
|
|
glucose homeostasis
|
GO:0042593 |
128 |
0.011
|
|
|
|
insulin secretion
|
GO:0030073 |
89 |
0.011
|
|
|
|
spermatid development
|
GO:0007286 |
108 |
0.011
|
|
|
|
morphogenesis of a branching structure
|
GO:0001763 |
203 |
0.011
|
|
|
|
morphogenesis of a branching epithelium
|
GO:0061138 |
193 |
0.011
|
|
|
|
regulation of protein transport
|
GO:0051223 |
163 |
0.011
|
|
|
|
transmembrane receptor protein tyrosine kinase signaling pathway
|
GO:0007169 |
247 |
0.011
|
|
|
|
regulation of store operated calcium entry
|
GO:2001256 |
4 |
0.011
|
|
|
|
regulation of protein catabolic process
|
GO:0042176 |
108 |
0.011
|
|
|
|
cell activation involved in immune response
|
GO:0002263 |
126 |
0.011
|
|
|
|
brain segmentation
|
GO:0035284 |
3 |
0.011
|
|
|
|
dna replication
|
GO:0006260 |
52 |
0.010
|
|
|
|
megakaryocyte differentiation
|
GO:0030219 |
26 |
0.010
|
|
|
|
regulation of cytoskeleton organization
|
GO:0051493 |
122 |
0.010
|
|
|
|
synaptic transmission
|
GO:0007268 |
329 |
0.010
|
|
|
|
rna splicing
|
GO:0008380 |
54 |
0.010
|
|
|
|
histone h4 k16 acetylation
|
GO:0043984 |
3 |
0.010
|
|
|
|
regulation of lipid biosynthetic process
|
GO:0046890 |
54 |
0.010
|
|
|
|
jnk cascade
|
GO:0007254 |
72 |
0.010
|
|
|
|
peptidyl serine modification
|
GO:0018209 |
83 |
0.010
|
|
|
|
aminoglycan metabolic process
|
GO:0006022 |
34 |
0.010
|
|
|
|
intrinsic apoptotic signaling pathway
|
GO:0097193 |
132 |
0.010
|
|
|
|
regulation of actin cytoskeleton organization
|
GO:0032956 |
84 |
0.010
|
|
|
|
regulation of mapk cascade
|
GO:0043408 |
248 |
0.010
|
|
|
|
histone lysine methylation
|
GO:0034968 |
50 |
0.010
|
|
|
|
maternal determination of anterior posterior axis embryo
|
GO:0008358 |
2 |
0.010
|
|
|
|
blood circulation
|
GO:0008015 |
195 |
0.010
|
|
|
|
glycosylation
|
GO:0070085 |
62 |
0.010
|
|
|
|
cardiocyte differentiation
|
GO:0035051 |
87 |
0.010
|
|
|
|
oocyte construction
|
GO:0007308 |
2 |
0.010
|
|
|
|
rna splicing via transesterification reactions with bulged adenosine as nucleophile
|
GO:0000377 |
43 |
0.010
|
|
|
|
regulation of cellular component size
|
GO:0032535 |
121 |
0.010
|
|
|
|
lung field specification
|
GO:0060424 |
3 |
0.010
|
|
|
|
cardiac cell fate specification
|
GO:0060912 |
2 |
0.010
|
|
|
|
mitotic nuclear division
|
GO:0007067 |
48 |
0.010
|
|
|
|
positive regulation of lipid metabolic process
|
GO:0045834 |
40 |
0.010
|
|
|
|
peptide hormone secretion
|
GO:0030072 |
109 |
0.010
|
|
|
|
cellular ion homeostasis
|
GO:0006873 |
165 |
0.010
|
|
